If a Stock Market Crash Is Coming, Investors Will Want to Own This Dividend King

Abbott Laboratories, a Dividend King with 54 consecutive years of dividend increases, is positioned as a defensive investment for potential market downturns. The company reported strong Q2 results with 13% sales growth and raised its full-year EPS guidance. With a 46% payout ratio and growth catalysts from medical devices and its $21 billion Exact Sciences acquisition in cancer diagnostics, Abbott offers both income stability and growth potential.